Adrienne D. Cox

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers

K. Wennerberg, C. Der, K. Lim, 2024, Science.

TEAD Inhibition Overcomes YAP1/TAZ-driven Primary and Acquired Resistance to KRASG12C Inhibitors.

C. Der, Andrew M. Waters, Jill Hallin, 2023, Cancer research.

Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer

C. Der, M. Pierobon, Run-Wei Yang, 2024, Science.

RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling

C. Der, N. Rashid, M. Pierobon, 2023, Science Signaling.